Importantly, we observed in the A375 xenograft tumor model that the T/B and T/M ratios were similar for both antibody isotypes and much higher for specific antibodies compared with a non-tumor targeted control IgE, demonstrating that target-binding capability was preserved in vivo. The gene discussed is IGHE; the disease is neoplasm.